Company / FCF Margin
TEVA PHARMACEUTICAL INDUSTRIES LTD FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
6.7%
FY2025
5-year range
1.5% / 7.0%
FY2021-FY2025
Trend
+46.8%
vs FY2024
Sector context
#50 of 133
Health Care
What the data says
At 6.7%, TEVA PHARMACEUTICAL INDUSTRIES LTD's fcf margin ranks #50 of 133 in the Health Care sector. FCF Margin returned to growth in FY2025 after 2 years of decline, reaching 6.7%.
Based on SEC 10-K filings.
6.7% in FY2025 with a 5-year CAGR of +2.8%.
Improved from 5.3% to 6.7% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -0.3pp
- 5-Year Change
- +2.8pp
- 10-Year Change
- -
Sector benchmark
#50 of 133 in Health CareTop 38% of 133This company 6.7% Sector average -632.8%
▼
+101.1% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 46.8% year-over-year.
- Currently 639.5pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 6.7% | +46.8% |
| FY2024 | 4.5% | -14.7% |
| FY2023 | 5.3% | -23.9% |
| FY2022 | 7.0% | +368.5% |
| FY2021 | 1.5% | -61.1% |
| FY2020 | 3.8% | +190.2% |
| FY2019 | 1.3% | -86.6% |
| FY2018 | 9.8% | +58.9% |
| FY2017 | 6.2% | -54.7% |
| FY2016 | 13.7% | -43.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026